▶ DSIP · SUBTOPIC · MECHANISM
DSIP Mechanism
For Laboratory Research Use Only. The mechanistic information below is descriptive of published research. No human dose is recommended. No clinical claim is made.
MECHANISM OF ACTION
Nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit cerebral venous blood during electrically induced sleep states. Modulates delta-wave EEG signaling in animal models; mechanism not fully characterized. Investigated for sleep, stress, and chronic pain.
PHARMACOKINETIC HALF-LIFE
Reported half-life for DSIP: Very short (minutes) plasma · longer CNS retention reported. Half-life determines the kinetic window across which receptor occupancy is maintained and frames the dosing rhythm used in published literature.
PRIMARY SEQUENCE
DSIP is a defined sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Synthesis proceeds via solid-phase peptide synthesis with HPLC-verified identity confirmation.
MECHANISM CATEGORIES
DSIP is tagged in 1 mechanism category on PEPPUDEX. Each category aggregates the broader pharmacology of related compounds.
Nootropic compounds act on canonical CNS pathways · BDNF / TrkB neurotrophic signaling, monoamine modulation, and GABAergic regulation. Russian-developed heptapeptides Semax and Selank are the most-studied research nootropics in the Peppu Studio catalog, both built on the same C-terminal Pro-Gly-Pro stabilizing strategy.
MECHANISTIC OUTCOMES IN LITERATURE
The following outcomes are the mechanistic endpoints reported in the peer-reviewed literature, with PEPPUDEX evidence grades. Grades reflect study quality and replication, not clinical recommendation.
Original Schoenenberger 1977 isolation paper described EEG-pattern shift toward slow-wave sleep in rabbits.
Russian preclinical literature on stress-axis modulation. Limited Western replication.
Limited published Western RCT evidence. Russian clinical literature describes use as sleep aid; no FDA or EMA trials.
MECHANISM Q+A
▶ How does DSIP work?
Mechanism is not fully characterized. Animal-model studies describe modulation of delta-wave EEG, HPA-axis stress response, and central monoamine signaling. No specific receptor has been definitively identified. Russian preclinical literature is the main evidence base.
▶ What's the half-life of DSIP?
Very short plasma half-life (minutes). CNS retention is reportedly longer, but the molecule is rapidly cleared from circulation. This is why research protocols typically use subcutaneous administration shortly before the intended sleep onset.
▶ DSIP vs melatonin · which is better for sleep?
Different mechanisms. Melatonin is the endogenous pineal hormone that signals circadian timing and is the standard research-supported sleep-onset compound. DSIP acts on a less-characterized delta-wave pathway and lacks the same evidence base. Melatonin is the better-validated research sleep aid.
CITED LITERATURE
- Schoenenberger GA, Monnier M. The isolation of a peptide which induces delta-sleep. Pflugers Arch 1977. PMID 195243. link
- Graf MV, Kastin AJ. Delta sleep-inducing peptide (DSIP): a review. Peptides 1986. link
RELATED PAGES
▶ LAST UPDATED · 2026-05-25